Ask AI

ClinicalThought

Share

Program Content

Activities

  • TROP2 ADCs in NSCLC
    Implementing TROP-2–Directed ADC Therapy in EGFR-Mutated NSCLC: From Clinical Trial Evidence to Clinical Decision-making
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2026

Provided by

ProCE Banner
ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.